New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S378

Introduced
1/9/24  

Caption

Provides for certain group home licensees to obtain Medicaid reimbursement for reservation of beds used by residents on therapeutic leave.

Impact

The legislation impacts existing state law by enhancing the protections available to individuals with developmental disabilities who utilize Medicaid. Under S378, group homes will be eligible for Medicaid reimbursement, allowing them to recover costs associated with reserving beds for residents who are away on therapeutic leave, up to 12 days per calendar year. This provision also requires that the absence is documented in the beneficiary’s individualized habilitation plan and authorized by their treatment team, thereby streamlining record-keeping and accountability within the group home system.

Summary

Senate Bill S378 proposes new provisions for group homes that accommodate individuals with developmental disabilities, specifically regarding the management of Medicaid benefits during therapeutic leave. The bill mandates that licensed group homes reserve beds for Medicaid beneficiaries who are temporarily absent from the facility for therapeutic, non-medical reasons. These reasons can include activities such as vacations or family visits, ensuring that a beneficiary's bed is not occupied by another individual during their leave period. This regulation is intended to provide continuity of care and support for beneficiaries by guaranteeing their accommodation during temporary absences.

Contention

Notable points of contention arising from the discussion around S378 include potential concerns regarding the administration of the bill and its implications for group home operations. Critics may question the feasibility of tracking therapeutic leave and ensuring compliance with the strict documentation requirements specified. Additionally, there may be debates surrounding reimbursement rates and how they reflect the actual costs incurred by group homes, which could affect the financial sustainability of facilities that serve these individuals. Proponents are likely to argue that the bill is a necessary step towards improving the quality of life for individuals with developmental disabilities by ensuring they have stable accommodations while engaging in necessary therapeutic activities.

Companion Bills

NJ S233

Carry Over Provides for certain group home licensees to obtain Medicaid reimbursement for reservation of beds used by residents on therapeutic leave.

Previously Filed As

NJ A4654

Regulates medication administration in certain licensed, residential facilities.

RI S3085

Increases the Medicaid reimbursement rate for Tier C services in licensed assisted living residences by 13% starting January 1, 2027.

WV SB909

Relating to Medicaid reimbursement rates for certain mental health diagnostic and therapeutic procedures

NJ A3591

Requires NJ FamilyCare reimbursement for pediatric medication management services provided for certain children by licensed pharmacist.

CA SB1109

Short-term residential therapeutic programs.

RI S0255

Establishes Medicaid fee-for-service reimbursement rates set by the general assembly as the rate floor for Medicaid managed care by home care, home nursing care and hospice providers licensed by the DOH and continue the EEOHH.

NJ A4870

Regulates medication administration in certain residential facilities.

NJ S438

Establishes minimum Medicaid reimbursement rate for structured day program services provided to beneficiary eligible for brain injury services.

RI H5774

Establishes Medicaid fee-for-service reimbursement rates set by the general assembly as the rate floor for Medicaid managed care by home care, home nursing care and hospice providers licensed by the DOH and continue the EEOHH.

RI S2363

Establishes the Medicaid fee-for-service reimbursement rates set by the general assembly as the rate floor for Medicaid managed care by home care, home nursing care and hospice providers.

Similar Bills

AL SB161

Medicaid; establishing coverage parity between opioid and nonopioid pain medications.

LA HB927

Provides relative to the Medicaid Pharmaceutical and Therapeutics Committee

MS SB2045

HIV medications; prohibit health plans and Medicaid from restricting dispensing of HIV/AIDS treatment.

MS SB2134

HIV medications; prohibit health plans and Medicaid from restricting dispensing of HIV/AIDS treatment.

FL S0070

Step-therapy Protocols

IL HB2584

INS-PRIOR AUTH HIV DRUG ACCESS

MS HB1370

Nurse practitioners; authorize to prescribe therapeutic shoes for persons with diabetes.

FL S1758

Public Assistance